Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/Net Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Net Sales(x) 4.113.667.217.334.94

What is the latest EV/Net Sales ratio of NATCO PHARMA ?

The latest EV/Net Sales ratio of NATCO PHARMA is 4.11 based on Mar2024 Consolidated results.
Year EV/Net Sales
Mar20244.11
Mar20233.66
Mar20227.21
Mar20217.33
Mar20204.94

How is EV/Net Sales of NATCO PHARMA Trending?

Years EV/Net Sales % Change
Mar2024 4.11
12.30
Mar2023 3.66
-49.24
Mar2022 7.21
-1.64
Mar2021 7.33
48.38
Mar2020 4.94 -

Other Financial Ratios of NATCO PHARMA


Compare EV/Net Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹22,926.6 Cr 13.5% 6.7% 54.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,697.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹157,449.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹117,778.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,871.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹97,046.2 Cr 3.2% -1% 27.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

13.5%

6.7%

54.6%

SENSEX

0.2%

-0.1%

7.2%


You may also like the below Video Courses